The incidence of collagen-associated adverse events in pediatric population with the use of fluoroquinolones: a nationwide cohort study in Taiwan
Authors:
Open Access
- 11 February 2020
- journal article
- research article
- Published by Springer Nature in BMC Pediatrics
- Vol. 20 (1) , 1-11
Abstract
Background: To evaluate the safety of using fluoroquinolones in pediatric population in Taiwan. Methods: Patients aged 0~18 years old with fluoroquinolones prescriptions ≥5 consecutive days during year 2000 to 2013 were selected from the National Health Insurance Research Database, 4-time case number were selected as controls. We evaluated the patient’s outcome after the use of fluoroquinolones by reviewing a newly diagnosis of the following collagen-associated adverse events by International Classification of Diseases, Ninth Revision, Clinical Modification codes, covering tendons rupture, retinal detachments, gastrointestinal tract perforation, aortic aneurysm or dissection. Results: Of the enrolled patients (n = 167,105), collagen-associated adverse effects developed in 85 cases (0.051%) in 6-month tracking, including 0.051% in the fluoroquinolones study cohort (17 in 33,421) and 0.051% (68 in 133,684) in the fluoroquinolones free comparison cohort. The crude hazard ratio for collagen-associated adverse events in the fluoroquinolones group was 0.997 (0.586–1.696; p = 0.990). After adjusting for age, sex, catastrophic illness, low-income household, seasons, levels of urbanization, and healthcare, the corrected hazard ratio in 6-month tracking with FQs was 1.330 (95% CI; 0.778–2.276; p = 0.255). Conclusions: There is no significant difference of collagen-associated adverse effects between fluoroquinolones group and fluoroquinolones free group from our data. We propose that fluoroquinolones for pediatric population in clinical practice may be not so harmful as previous references reported.Keywords
All Related Versions
Funding Information
- Tri-Service General Hospital (TSGH-C108-003, TSGH-B-109010)
This publication has 32 references indexed in Scilit:
- Tendon Injury and Fluoroquinolone Use: A Systematic ReviewDrug Safety, 2013
- Systemic use of fluoroquinolone in childrenKorean Journal of Pediatrics, 2013
- Observational Studies: Cohort and Case-Control StudiesPlastic and Reconstructive Surgery, 2010
- Diabetic retinopathyThe Lancet, 2010
- Hypertension and target organ damage in children and adolescentsJournal Of Hypertension, 2007
- Noncompliance in Current Antibiotic PracticeInfectious Diseases in Clinical Practice, 2006
- Peripheral Arterial Disease in Patients With DiabetesJACC, 2006
- Fluoroquinolones cause changes in extracellular matrix, signalling proteins, metalloproteinases and caspase-3 in cultured human tendon cellsToxicology, 2005
- Lifetime risk of developing coronary heart diseaseThe Lancet, 1999
- Colon perforation in Ehlers-Danlos syndromeThe American Journal of Surgery, 1984